Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 122† | 136† | 124† | 102† | 125† |
| Net profit | 15 | 20 | 17 | 13 | 14† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| MAHENDRA SINGH CHAWLA | Executive Director | June 30, 2026 |
| PARESH CHAWLA | Executive Director | June 30, 2026 |
| PRAVIN CHANDRA SHAH | Executive Director | June 30, 2026 |
| SHITUL SHAH | Executive Director | June 30, 2026 |
| VITTHAL KOTHANA | Executive Director | June 30, 2026 |
| JYOTI JAIN | Independent Director | June 30, 2026 |
| PRATIBHA LUNAWAT | Independent Director | June 30, 2026 |
| PRATIK SHAH | Independent Director | June 30, 2026 |
| SANKET BAHETI | Independent Director | June 30, 2026 |
| SUNIL KUMAR VALECHA | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
